StockDuty ← Dashboard Oct 12, 2026 08:20 PM ET
SignalCorporate

Nurix Therapeutics GAAP EPS of $4.73 beats by $1.64, revenue of $673.1M beats by $193.58M

Nurix Therapeutics EPS beat by $1.64 and revenue beat by $193.58M.

Nurix Therapeutics EPS beat by $1.64 and revenue beat by $193.58M.
Nurix Therapeutics EPS beat by $1.64 and revenue beat by $193.58M. — impact context not separately stored; see What changed.
Sources